超声引导射频与微波消融治疗甲状腺微小乳头状癌的效果对比

摘要
图/表
参考文献(23)
相关文章 (15)

全文: PDF (546 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨超声引导下射频消融（RFA）治疗甲状腺微小乳头状癌（PTMC）的效果，并分析其对患者应激反应的影响。方法选取2016年3月～2017年3月在浙江省湖州市中心医院确诊为PTMC患者97例，根据治疗方式不同将所有研究对象分为射频消融组（观察组，n = 45）和微波消融组（对照组，n = 52）。分别于术后第1、3、6、12个月超声随访，观察两组患者病灶体积大小变化，并比较两组患者术后并发症发生率及血清炎性因子[白细胞介素-6（IL-6）、肿瘤坏死因子-α（TNF-α）以及C反应蛋白（CRP）]水平的变化。结果两组患者术后并发症总发生率比较，差异无统计学意义（P ＞ 0.05），均未出现严重并发症；术后随访期间未见原发灶局部复发或颈部淋巴结转移，超声提示两组患者术后1个月消融灶体积较术前增大，之后消融灶体积逐渐缩小，术后6、12个月，其体积明显缩小，与术前比较差异有统计意义（P ＜ 0.05），各随访时间点两组消融灶体积大小及病灶体积缩小率比较，差异无统计学意义（P ＞ 0.05）；两组患者术后24 h血清IL-6、TNF-α及CRP水平均较术前升高（P ＜ 0.05）；术后72 h血清IL-6、TNF-α及CRP水平基本恢复，与术前比较，差异无统计学意义（P ＞ 0.05）。两组患者术后24 h和72 h血清IL-6、TNF-α及CRP水平比较，差异无统计学意义（P ＞ 0.05）。结论超声引导下射频消融是治疗PTMC的一种有效、安全的方法。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	沈吉徐华军熊伟律

关键词 ：甲状腺微小乳头状癌, 射频消融, 微波消融, 应激

Abstract：Objective To investigate the efficacy of ultrasound guided radiofrequency ablation (RFA) in the treatment of papillary thyroid microcarcinoma (PTMC) and to analyze the effect of RFA on the stress response of the patients. Methods From March 2016 to March 2017, 97 patients with PTMC were selected in Huzhou Central Hospital of Zhejiang Province. According to different treatment methods, all subjects were divided into RFA group (observation group, n = 45) and microwave ablation group (control group, n = 52). Ultrasonic follow up was performed at 1, 3, 6 and 12 months after operation respectively, the lesion foci volume of patients was observed, and the incidence of postoperative complications, the levels of serum inflammatory factors [interleukin -6 (IL-6), tumor necrosis factor -α (TNF-α) and C reactive protein (CRP)] were compared between the two groups. Results The total incidence complications after operation in the two groups was not statistically significant (P ＞ 0.05), and no serious complications occurred. No local recurrence or cervical lymph node metastases was found during the follow-up period, ultrasound showed that the volume of ablation in the two groups were increased at 1 month after operation, afterwards, the volume of the ablation range were gradually reduced. The volume decreased significantly at 6 and 12 months after operation, compared with before operation, the difference were statistically significant (P ＜ 0.05). There was no significant difference in the volume reduction rate and volume of ablation foci between the two groups at each follow-up time point (P ＞ 0.05). Serum IL-6, TNF-α and CRP levels of the two groups were higher 24 h after surgery than before (P ＜ 0.05). The levels of serum IL-6, TNF-α and CRP levels recovered basically 72 h after surgery, with no statistically significant difference compared with that before surgery (P ＞ 0.05). There was no significant difference in the levels of serum IL-6, TNF-α and CRP levels between the two groups 24 h and 72 h after surgery (P ＞ 0.05). Conclusion Ultrasound guided RFA is an effective and safe method for the treatment of PTMC.

Key words： Papillary thyroid microcarcinoma Radiofrequency ablation Microwave ablation Stress

基金资助:浙江省湖州市科技局项目（2016GY34）。

引用本文:

沈吉徐华军熊伟律. 超声引导射频与微波消融治疗甲状腺微小乳头状癌的效果对比[J]. 中国医药导报, 2019, 16(7): 131-135.
SHEN Ji XU Huajun XIONG Weilü. Comparison of ultrasound-guided radiofrequency ablation and microwave ablation for the treatment of papillary thyroid microcarcinoma. 中国医药导报, 2019, 16(7): 131-135.

链接本文:

http://www.yiyaodaobao.com.cn/CN/ 或 http://www.yiyaodaobao.com.cn/CN/Y2019/V16/I7/131

[1] Ito Y，Oda H，Miyauchi A. Insights and clinical questions about the active surveillance of low-risk papillary thyroid microcarcinomas [J]. Endocr J，2016，63（4）：323-328.
[2] Vorasubin N，Nguyen C，Wang M. Risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma：A meta-analysis [J]. Ear Nose Throat J，2016，95（2）：73-77.
[3] Kim TY，Shong YK. Active Surveillance of Papillary Thyroid Microcarcinoma：A Mini-Review from Korea [J]. Endocrinol Metab（Seoul），2017，32（4）：399-406.
[4] Witt RL. What is the best treatment of incidental papillary thyroid microcarcinoma? [J]. Laryngoscope，2016，126（10）：2203-2204.
[5] 葛明华，徐栋.甲状腺良性结节、微小癌及颈部转移性淋巴结热消融治疗浙江省专家共识（2015版）[J].中国普通外科杂志，2016，25（7）：944-946.
[6] Ahn HS，Kim SJ，Park SH，et al. Radiofrequency ablation of benign thyroid nodules：evaluation of the treatment efficacy using ultrasonography [J]. Ultrasonography，2016，35（3）：244-252.
[7] Park HS，Back JH，Na DG. Benign thyroid nodules treatment using percutaneous laser ablation （PLA） and radiofrequency ablation （RFA） [J]. Int J Hyperthermia，2017， 33（3）：295-299.
[8] 张燕，范晓翔，章美武.超声引导下甲状腺囊实性结节射频消融与酒精消融疗效比较[J].中华超声影像学杂志，2016，25（4）：318-323.
[9] 孙崇启，赵静.射频消融技术临床应用现状[J].介入放射学杂志，2007，16（7）：502-504.
[10] Zhang B，Moser MAJ，Zhang EM，et al. A review of radiofrequency ablation：Large target tissue necrosis and mathematical modelling [J]. Physica Medica，2016，32（8）：961-971.
[11] Luo W，Zhang Y，He G，et al. Effects of radiofrequency ablation versus other ablating techniques on hepatocellular carcinomas：a systematic review and meta-analysis [J]. World J Surg Oncol，2017，15（1）：126.
[12] 赵林蔚，朱利杰，张优.肾动脉射频消融去交感神经术研究进展[J].中华实用诊断与治疗杂志，2017，31（2）：194-196.
[13] 陈锦州，黄建强，赵卫.射频消融在骨肿瘤中的应用及研究进展[J].医学综述，2010，16（23）：3591-3593.
[14] Park HS，Baek JH，Park AW，et al. Thyroid Radiofrequency Ablation：Updates on Innovative Devices and Techniques [J]. Korean J Radiol，2017，18（4）：615-623.
[15] 张浩，董文武.射频消融治疗甲状腺癌的现状与思考[J].中华外科杂志，2017，55（8）：574-578.
[16] 田文，王宇，郗洪庆，等.甲状腺疾病射频消融治疗现状与争议[J].中国实用外科杂志，2018，38（1）：75-78.
[17] 鲁瑶.甲状腺结节射频消融治疗的是与非[J].临床外科杂志，2017，25（11）：818-819.
[18] 郭真，卢崇亮.甲状腺微小乳头状癌的研究进展[J].中国普通外科杂志，2012，21（5）：597-601.
[19] 田海英，马宁，徐栋，等.超声引导射频消融治疗甲状腺微小癌疗效分析[J].中国医学影像技术，2018，34（4）：514-517.
[20] 朱佳琳，徐勇，魏玺，等.射频消融治疗甲状腺微小乳头状癌的临床研究[J].中华超声影像学杂志，2017，26（4）：357-359.
[21] 李建如，罗渝昆，李岩密，等.超声引导下射频消融治疗甲状腺微小乳头状癌的疗效分析[J].解放军医学院学报，2016，37（8）：823-826.
[22] 王君韬，谈建.严重创伤与应激反应分子机制的探讨[J].中国基层医药，2003，10（2）：169-170.
[23] Alper B，Erdogan B，Erdogan M?魶，et al. Associations of Trauma Severity with Mean Platelet Volume and Levels of Systemic Inflammatory Markers （IL1β，IL6，TNFα，and CRP） [J]. Mediators Inflamm，2016，2016（4）：9 894 716.